Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis

被引：0
|
作者：
Machaon M Bonafede
Anupama Kalsekar
Manjiri Pawaskar
Kimberly M Ruiz
Amelito M Torres
Karen R Kelly
Suellen M Curkendall
机构：
[1] Thomson Reuters Inc,Outcomes Research
[2] Bristol Myers Squibb,Global Health Economics and Outcomes Research
[3] Eli Lilly and Company,Global Health Outcomes: Endocrine/Obesity/Metabolism
[4] Lilly Technology Center,Outcomes Research
[5] Thomson Reuters Inc,Healthcare Research and Analytics
[6] GE Healthcare,Diabetes and Devices Platform
[7] Eli Lilly and Company,undefined
[8] Lilly Technology Center,undefined
来源：
BMC Endocrine Disorders | / 11卷
关键词：
Insulin Therapy; Human Insulin; Basal Insulin; Index Insulin; Mealtime Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Bonafede, Machaon M.
    Kalsekar, Anupama
    Pawaskar, Manjiri
    Ruiz, Kimberly M.
    Torres, Amelito M.
    Kelly, Karen R.
    Curkendall, Suellen M.
    BMC ENDOCRINE DISORDERS, 2011, 11
  • [2] A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE WITH INSULIN IN PATIENTS WITH TYPE 2 DIABETES ADDING MEALTIME INSULIN TO A BASAL REGIMEN
    Kalsekar, A.
    Bonafede, M. M.
    Pawaskar, M. D.
    McGuffie, K.
    Torres, A.
    Kelly, K. R.
    Curkendall, S.
    VALUE IN HEALTH, 2009, 12 (07) : A413 - A413
  • [3] A retrospective database analysis of insulin use patterns in insulin-naive patients with type 2 diabetes initiating basal insulin or mixtures
    Bonafede, Machaon M. K.
    Kalsekar, Anupama
    Pawaskar, Manjiri
    Ruiz, Kimberly M.
    Torres, Amelito M.
    Kelly, Karen R.
    Curkendall, Suellen M.
    PATIENT PREFERENCE AND ADHERENCE, 2010, 4 : 147 - 156
  • [4] Pramlintide or mealtime insulin added to basal insulin treatment in patients with type 2 diabetes
    Riddle, M.
    Pencek, R.
    Charenkavanich, S.
    Lutz, K.
    Porter, L.
    Wilhelm, K.
    DIABETOLOGIA, 2008, 51 : S407 - S408
  • [5] Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis
    He, Xiaoning
    Chen, Liming
    Wang, Ke
    Wu, Haiya
    Wu, Jing
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 237 - 245
  • [6] Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
    Riddle, Matthew
    Pencek, Richard
    Charenkavanich, Supoat
    Lutz, Karen
    Wilhelm, Ken
    Porter, Lisa
    DIABETES CARE, 2009, 32 (09) : 1577 - 1582
  • [7] Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis
    Pscherer, Stefan
    Chou, Engels
    Dippel, Franz-Werner
    Rathmann, Wolfgang
    Kostev, Karel
    PRIMARY CARE DIABETES, 2015, 9 (05) : 377 - 384
  • [8] Primary Care Perspectives: The Effective Use of Mealtime and Basal Insulin Regimens in Patients with Type 2 Diabetes
    Banwell, Brenda
    Giovannoni, Gavin
    Hawkes, Chris
    Lublin, Fred
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (04) : A1 - A3
  • [9] Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis
    Aroda, Vanita R.
    Nielsen, Nick
    Mangla, Kamal K.
    Multani, Jasjit
    Divino, Victoria
    Namvar, Tarlan
    Rajpura, Jigar
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (02)
  • [10] Comparison of mealtime pramlintide, insulin, or a combination of both, when added to basal insulin treatment in patients with type 2 diabetes
    Karounos, D.
    Pencek, R.
    Huang, W.
    Miller, S.
    Lutz, K.
    Porter, L.
    DIABETOLOGIA, 2009, 52 : S358 - S358
12345